115 related articles for article (PubMed ID: 21459058)
1. [Plasmapheresis as treatment for severe hypertriglyceridemia].
Manrique Franco K; Sánchez-Vilar Burdiel O; Aragón Valera C; Sánchez Fernández MS; Rovira Loscos A
Endocrinol Nutr; 2011; 58(6):319-20. PubMed ID: 21459058
[No Abstract] [Full Text] [Related]
2. Islet enhancer vildagliptin: a powerful partner with metformin for the treatment of patients with type 2 diabetes.
Scherbaum WA
Diabetes Obes Metab; 2009 May; 11 Suppl 2():1-2. PubMed ID: 19385977
[No Abstract] [Full Text] [Related]
3. Effects of vildagliptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with metformin.
Bosi E; Camisasca RP; Collober C; Rochotte E; Garber AJ
Diabetes Care; 2007 Apr; 30(4):890-5. PubMed ID: 17277036
[TBL] [Abstract][Full Text] [Related]
4. Improved meal-related insulin processing contributes to the enhancement of B-cell function by the DPP-4 inhibitor vildagliptin in patients with type 2 diabetes.
Ahrén B; Pacini G; Tura A; Foley JE; Schweizer A
Horm Metab Res; 2007 Nov; 39(11):826-9. PubMed ID: 17992639
[TBL] [Abstract][Full Text] [Related]
5. Three new drugs for type 2 diabetes.
Drug Ther Bull; 2008 Jul; 46(7):49-52. PubMed ID: 18603639
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacological sheet. Vildagliptin, oral administration (GALVUS)].
J Pharm Belg; 2009 Jun; (2):64-6. PubMed ID: 19739530
[No Abstract] [Full Text] [Related]
7. Case 2. Recurrence of myocardial infarction.
Tanser P; Archer S; Feldman R
Can J Cardiol; 2000 Aug; 16 Suppl E():24E-26E. PubMed ID: 10906622
[TBL] [Abstract][Full Text] [Related]
8. Vildagliptin and vildagliptin/metformin: new drug. Same limited efficacy as sitagliptin in type 2 diabetes.
Prescrire Int; 2008 Oct; 17(97):188. PubMed ID: 19534040
[No Abstract] [Full Text] [Related]
9. Selective whole blood lipoprotein apheresis to prevent pancreatitis in drug refractory hypertriglyceridemia.
Hovland A; Hardersen R; Mollnes TE; Lappegård KT
JOP; 2010 Sep; 11(5):467-9. PubMed ID: 20818118
[TBL] [Abstract][Full Text] [Related]
10. [DPP-4 inhibitors in clinical use. Therapy without the risk of hypoglycaemia].
Gallwitz B
Pharm Unserer Zeit; 2010 Mar; 39(2):114-8. PubMed ID: 20196038
[No Abstract] [Full Text] [Related]
11. Efficacy and tolerability of initial combination therapy with vildagliptin and pioglitazone compared with component monotherapy in patients with type 2 diabetes.
Rosenstock J; Kim SW; Baron MA; Camisasca RP; Cressier F; Couturier A; Dejager S
Diabetes Obes Metab; 2007 Mar; 9(2):175-85. PubMed ID: 17300593
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of hyperglycemia in adult-onset diabetes mellitus].
Yki-Järvinen H
Duodecim; 1999; 115(10):1155-64. PubMed ID: 11877855
[No Abstract] [Full Text] [Related]
13. The DPP-4 inhibitor vildagliptin: robust glycaemic control in type 2 diabetes and beyond.
Panina G
Diabetes Obes Metab; 2007 Sep; 9 Suppl 1():32-9. PubMed ID: 17877545
[TBL] [Abstract][Full Text] [Related]
14. Effects of one year treatment of vildagliptin added to pioglitazone or glimepiride in poorly controlled type 2 diabetic patients.
Derosa G; Maffioli P; Ferrari I; Mereu R; Ragonesi PD; Querci F; Franzetti IG; Gadaleta G; Ciccarelli L; Piccinni MN; D'Angelo A; Salvadeo SA
Horm Metab Res; 2010 Aug; 42(9):663-9. PubMed ID: 20560108
[TBL] [Abstract][Full Text] [Related]
15. [Sitagliptin. DPP-4 inhibitors as a useful extension of oral diabetes therapy?].
Matthes J; Faust M
Dtsch Med Wochenschr; 2008 Oct; 133(43):2233-7. PubMed ID: 18924057
[No Abstract] [Full Text] [Related]
16. The role of vildagliptin in the management of type 2 diabetes mellitus.
Kleppinger EL; Helms K
Ann Pharmacother; 2007 May; 41(5):824-32. PubMed ID: 17456545
[TBL] [Abstract][Full Text] [Related]
17. [Not Available].
Honka M
Vnitr Lek; 2013 Dec; 59(12):1039-40. PubMed ID: 24466605
[No Abstract] [Full Text] [Related]
18. Insulin treatment for type 2 diabetes: when to start, which to use.
Hamaty M
Cleve Clin J Med; 2011 May; 78(5):332-42. PubMed ID: 21536829
[TBL] [Abstract][Full Text] [Related]
19. Adding a DPP-4 inhibitor to metformin therapy may be safer than you think.
Aravind SR
Curr Med Res Opin; 2014 May; 30(5):791-4. PubMed ID: 24517395
[No Abstract] [Full Text] [Related]
20. Dipeptidyl peptidase-4 inhibitors: clinical data and clinical implications.
Ahrén B
Diabetes Care; 2007 Jun; 30(6):1344-50. PubMed ID: 17337494
[No Abstract] [Full Text] [Related]
[Next] [New Search]
